Avinger Future Growth
Future criteria checks 2/6
Avinger is forecast to grow earnings and revenue by 15.1% and 24.7% per annum respectively while EPS is expected to grow by 66.4% per annum.
Key information
15.1%
Earnings growth rate
66.4%
EPS growth rate
Medical Equipment earnings growth | 18.3% |
Revenue growth rate | 24.7% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 13 Nov 2023 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 14 | -13 | N/A | N/A | 1 |
12/31/2024 | 11 | -15 | N/A | N/A | 1 |
12/31/2023 | 8 | -17 | N/A | N/A | 1 |
9/30/2023 | 8 | -19 | -14 | -14 | N/A |
6/30/2023 | 8 | -22 | -14 | -14 | N/A |
3/31/2023 | 8 | -22 | -15 | -15 | N/A |
12/31/2022 | 8 | -27 | -17 | -17 | N/A |
9/30/2022 | 9 | -28 | -18 | -18 | N/A |
6/30/2022 | 9 | -29 | -18 | -18 | N/A |
3/31/2022 | 9 | -27 | -17 | -17 | N/A |
12/31/2021 | 10 | -22 | -16 | -16 | N/A |
9/30/2021 | 10 | -21 | -15 | -15 | N/A |
6/30/2021 | 10 | -21 | -15 | -15 | N/A |
3/31/2021 | 9 | -22 | -15 | -15 | N/A |
12/31/2020 | 9 | -23 | -15 | -15 | N/A |
9/30/2020 | 9 | -23 | -15 | -15 | N/A |
6/30/2020 | 9 | -23 | -16 | -16 | N/A |
3/31/2020 | 10 | -24 | -16 | -16 | N/A |
12/31/2019 | 9 | -23 | -17 | -17 | N/A |
9/30/2019 | 9 | -24 | -17 | -18 | N/A |
6/30/2019 | 8 | -25 | -17 | -17 | N/A |
3/31/2019 | 8 | -26 | -18 | -18 | N/A |
12/31/2018 | 8 | -36 | -18 | -18 | N/A |
9/30/2018 | 8 | -39 | -20 | -20 | N/A |
6/30/2018 | 8 | -43 | -24 | -24 | N/A |
3/31/2018 | 8 | -49 | -28 | -28 | N/A |
12/31/2017 | 10 | -49 | -35 | -34 | N/A |
9/30/2017 | 13 | -52 | -40 | -40 | N/A |
6/30/2017 | 16 | -55 | N/A | -44 | N/A |
3/31/2017 | 18 | -55 | N/A | -50 | N/A |
12/31/2016 | 19 | -56 | N/A | -53 | N/A |
9/30/2016 | 17 | -56 | N/A | -54 | N/A |
6/30/2016 | 15 | -56 | N/A | -55 | N/A |
3/31/2016 | 13 | -53 | N/A | -49 | N/A |
12/31/2015 | 11 | -50 | N/A | -41 | N/A |
9/30/2015 | 11 | -44 | N/A | -35 | N/A |
6/30/2015 | 11 | -40 | N/A | -28 | N/A |
3/31/2015 | 11 | -37 | N/A | -24 | N/A |
12/31/2014 | 11 | -32 | N/A | -22 | N/A |
9/30/2014 | 12 | -32 | N/A | -23 | N/A |
6/30/2014 | 12 | -33 | N/A | -27 | N/A |
3/31/2014 | 12 | -37 | N/A | -34 | N/A |
12/31/2013 | 13 | -40 | N/A | -41 | N/A |
12/31/2012 | 9 | -34 | N/A | -35 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: VG20 is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: VG20 is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: VG20 is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: VG20's revenue (24.7% per year) is forecast to grow faster than the German market (4.6% per year).
High Growth Revenue: VG20's revenue (24.7% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if VG20's Return on Equity is forecast to be high in 3 years time